1. Combined robotic surgery for concomitant treatment of endometrial cancer and obesity
- Author
-
Mezzapesa, Francesco, Di Costanzo, Stella, Coadă, Camelia Alexandra, Bernante, Paolo, Balsamo, Francesca, Garelli, Silvia, Genovesi, Lucia, Pasquini, Pietro, Lambertini, Agnese, Caramelli, Fabio, De Iaco, Pierandrea, and Perrone, Anna Myriam
- Abstract
Background: Endometrial Cancer (EC) is strongly linked to obesity. Bariatric surgery is recognized as a long-term solution for weight loss in severely obese patients. This pilot study investigates the feasibility, intraoperative and 30-day morbidity outcomes of integrating gynecological surgical staging and bariatric robotic surgery in class II and III obese patients affected by early EC or Endometrial Intraepithelial Neoplasia (EIN). Methods: Patients aged over 18 years old with early EC or EIN and class II and III obesity (Body mass index (BMI) ≥ 35 kg/m
2 ) who are surgical and anesthesiologic candidates. Standard robotic surgery for early EC staging performed alone (THBSO group) or in conjunction with sleeve gastrectomy (THBSO + SG group) for obesity management was proposed. Results: Of the 13 patients who met the inclusion criteria, 5 (38.46%) opted for combined surgery. The groups showed a significant difference in preoperative BMI (49.68 kg/m2 vs. 40.24 kg/m2 p= 0.017 with and without SG), preoperative weight (143.92 kg vs. 105.62 kg p= 0.004 with and without SG), preoperative (p = 0.01) and postoperative (p= 0.005) aspartate transaminase (AST). The THBSO + SG group had higher anesthesia induction end-tidal carbon dioxide (ETCO2) (p= 0.05), final Partial pressure of carbon dioxide (PaCO2) (p= 0.044), anesthesia induction lactate (p= 0.001) and final lactate (p = 0.011) without a significant difference in final pH (p= 0.31). Operative time was longer in the THBSO + SG group (p< 0.001), but this did not result in longer ICU (p= 0.351), total hospital stays (p= 0.208), nor increased blood loss and transfusion. The simultaneous combined approach had an 80% success rate. At 6 months, the THBSO + SG group achieved significantly greater weight loss than the THBSO group (ΔBMI − 11.81 kg/m2 vs − 1.72 kg/m2 , p= 0.003, with and without SG). Conclusion: Integrating robotic EC staging with SG in obese women with early EC increased the operative time without increasing intraoperative risks, early and 30 days post-surgery complication and offering a promising approach to simultaneously treating both conditions.- Published
- 2024
- Full Text
- View/download PDF